PRDX1 and colorectal carcinoma: The above data demonstrate that to maintain their high proliferative capacity, CRC cells rapidly degrade newly synthesized NOXA by enhancing the activity of its ubiquitin E3 ligase CRL5, which is at least partially controlled by PRDX1 through linking UBE2F with CUL5.